News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Luminex Corporation Reports Second Quarter 2008 Results
August 7, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AUSTIN, Texas--(BUSINESS WIRE)--Luminex Corporation (NASDAQ:LMNX) today announced financial results for the second quarter and six months ended June 30, 2008. Financial and operating highlights include the following:
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Manufacturing
Violations at Novo’s Indiana Plant ‘Unacceptable,’ FDA Says
October 14, 2025
·
2 min read
·
Tristan Manalac
Artificial intelligence
Takeda Makes $1B+ AI Bet With Nabla to Build Out Early Pipeline
October 14, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Novo Retreats From Cell Therapy, Axes Hundreds as Restructuring Rolls On
October 13, 2025
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH EVOTEC
Strategic Drug Development in a Funding Crisis: Expert Insights on Risk Profiling, Efficiency, and Innovation
October 13, 2025
·
8 min read
·
BioSpace Insights
